Faculty profile

Robert Korneluk

ResearcherMolecular GeneticsUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Robert Korneluk

Researcher

Molecular Genetics

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2021.
Principal investigator on 11 research grants (11 CIHR), most recently in 2018.
Supervised 2 trainees who won CIHR awards, most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Apoptosis Cancer Immunotherapy Combination Synergy Iap Antagonists Immune Checkpoint Inhibitors Smac Mimetics Tnfalpha Tumor Immunity

Latest papers

Author Correction: Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages.
Scientific reports · 2021
Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages.
Scientific reports · 2021
Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.
PloS one · 2018

All 3 publications

Latest funding

Alternative NF-kB Signaling in Muscle Regeneration and Muscular Dystrophy
CIHR · 2023 · Supervisor
$90,000
Cellular inhibitor of apoptosis 1 (cIAP1) as a novel therapeutic target for the treatment of Duchenne muscular dystrophy
CIHR · 2019 · Supervisor
$135,000
Combined IAP antagonism and immunotherapy for cancer treatment
CIHR · 2018 · Nominated PI
$937,126

All 15 grants and awards

Alternative NF-kB Signaling in Muscle Regeneration and Muscular Dystrophy

SupervisorCIHR2023CIHR REDI Early Career Transition Award - Rare Diseases

Principal investigators: Lala-Tabbert, Neena

Keywords: Duchenne Muscular Dystrophy; Muscle Regeneration; Nf-Kb

$90,000

Cellular inhibitor of apoptosis 1 (cIAP1) as a novel therapeutic target for the treatment of Duchenne muscular dystrophy

SupervisorCIHR2019CIHR Fellowship

Principal investigators: Lala-Tabbert, Neena

Keywords: Duchenne Muscular Dystrophy; Histology; Immunoblotting; Inhibitor Of Apoptosis; Mdx Mice; Skeletal Muscle; Smac Mimetic Compounds

$135,000

Combined IAP antagonism and immunotherapy for cancer treatment

Nominated PICIHR2018Project Grant

Principal investigators: Korneluk, Robert G

Keywords: Apoptosis; Bladder Cancer; Cancer Immunotherapy; Combination Synergy; Cytotoxic T Lymphocyte; Iap Antagonists; Immune Checkpoint Inhibitors; Smac Mimetics; Tnfalpha; Tumor Immunity

$937,126

The role of the Inhibitors of Apoptosis (IAPs) in health and disease

Nominated PICIHR2018Foundation Grant

Principal investigators: Korneluk, Robert G

Keywords: Apoptosis; Cancer Immunotherapy; Cell Signaling; Drug Therapy; Immunity; Translational Research; Tumour Microenvironment

$2,905,410

Combination of IAP antagonism and immune checkpoint blockade to treat brain cancer

Nominated PICIHR2016Operating Grant: Targeting High Fatality Cancers - Innovation Grant

Principal investigators: Korneluk, Robert G

Keywords: Apoptosis; Cancer Immunotherapy; Combination Synergy; Cytotoxic T-Lymphocyte; Glioblastoma; Iap Antagonists; Immune Checkpoint Inhibitors; Smac Mimetics; Tnfalpha; Tumor Immunity

$100,000

Use of Smac Mimetics in Specific Killing of HIV-infected Macrophages

Co-investigatorCIHR2016Operating Grant: Innovative Biomedical and Clinical HIV/AIDS Research

Principal investigators: Kumar, Ashok

Keywords: Anti-Apoptotic Genes; Hiv; Iaps; Macrophages; Samc Mimetics; Signal Transduction

$250,000

Combined IAP antagonism and immunotherapy for cancer treatment

Nominated PICIHR2013Operating Grant

Principal investigators: Korneluk, Robert G

Keywords: Apoptosis; Biomarkers; Cancer; Iaps; Immune Stimulators; Immunotherapy; Oncolytic Virus; Preclinical; Tumor Models; Vaccine

$794,885

Role of cellular Inhibitors of Apoptosis (cIAPs) in muscle biology and disease

Nominated PICIHR2012Operating Grant

Principal investigators: Korneluk, Robert G

Keywords: Inhibitors Of Apoptosis (Iaps); Muscular Dystrophy; Nuclear Factor-Kappa B (Nf-Kb); Skeletal Muscle Atrophy; Skeletal Muscle Regeneration; Tumor Necrosis Factor

$786,370

The role of the Inhibitors of Apoptosis (IAPs) in cancer

Nominated PICIHR2010Operating Grant

Principal investigators: Korneluk, Robert G

Keywords: Ablation; Antagonists; Cancer; Caspases; Inhibitors Of Apoptosis (Iaps); Mechanism; Proteasome Degradation; Signaling; Therapy; Ubiquitination

$860,078

Anti-apoptotic therapy for the treatment of retinal degeneration: basic science to clinical application

Principal investigatorCIHR2009Team Grant: Vision, Hearing and Communication Disorders - LOI

Principal investigators: Tsilfidis, Catherine; Korneluk, Robert G

Keywords: Apoptosis; Gene Therapy; Nanoparticles; Retinal Degeneration

$3,739

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Robert Korneluk

Research

Latest papers

Latest funding

Author Correction: Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages.

Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages.

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.

Alternative NF-kB Signaling in Muscle Regeneration and Muscular Dystrophy

Cellular inhibitor of apoptosis 1 (cIAP1) as a novel therapeutic target for the treatment of Duchenne muscular dystrophy

Combined IAP antagonism and immunotherapy for cancer treatment

The role of the Inhibitors of Apoptosis (IAPs) in health and disease

Combination of IAP antagonism and immune checkpoint blockade to treat brain cancer

Use of Smac Mimetics in Specific Killing of HIV-infected Macrophages

Combined IAP antagonism and immunotherapy for cancer treatment

Role of cellular Inhibitors of Apoptosis (cIAPs) in muscle biology and disease

The role of the Inhibitors of Apoptosis (IAPs) in cancer

Anti-apoptotic therapy for the treatment of retinal degeneration: basic science to clinical application

Frequent collaborators

Ashok Kumar

Edana Cassol